Pacira BioSciences
PCRX
PCRX
270 hedge funds and large institutions have $3.49B invested in Pacira BioSciences in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 82 increasing their positions, 103 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
2.3% less ownership
Funds ownership: 115.94% → 113.64% (-2.3%)
20% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 103
Holders
270
Holding in Top 10
3
Calls
$9.92M
Puts
$4.45M
Top Buyers
| 1 | +$37.7M | |
| 2 | +$12.8M | |
| 3 | +$11.9M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.76M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$9.23M |
Top Sellers
| 1 | -$28M | |
| 2 | -$21.9M | |
| 3 | -$21.7M | |
| 4 |
D.E. Shaw & Co
New York
|
-$18.2M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$15M |